BPH Global Ltd (ASX:BP8)

Market Cap	2.10M
Revenue (ttm)	160.90K
Net Income (ttm)	-1.69M
Shares Out	1.05B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	102,591
Average Volume	2,089,126
Open	0.0020
Previous Close	0.0020
Day's Range	0.0020 - 0.0020
52-Week Range	0.0010 - 0.0060
Beta	0.37
RSI	49.72
Earnings Date	Aug 29, 2025

About BPH Global

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company’s products include raw bird’s nest and processed bird’s nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. BPH Globa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1984
• Employees: 31
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: BP8

Financial Performance

In 2024, BPH Global's revenue was 109,965, an increase of 32338.05% compared to the previous year's 339. Losses were -2.65 million, -45.07% less than in 2023.